Perlecan and Prostate Cancer Growth
Author Information
Author(s): Datta Milton W, Hernandez Ana Maria, Schlicht Michael J, Kahler Andrea J, DeGueme Amy M, Dhir Rajiv, Shah Rajal B, Farach-Carson Cindy, Barrett Andrea, Datta Sumana
Primary Institution: Emory University
Hypothesis
Does Perlecan regulate prostate cancer cell growth through the Sonic Hedgehog pathway?
Conclusion
Perlecan is a key regulator of the Sonic Hedgehog pathway in prostate tumors and operates independently of androgen signaling.
Supporting Evidence
- Perlecan expression correlates with high Gleason scores in prostate cancer tissues.
- Inhibition of Perlecan decreases cell growth in prostate cancer cell lines.
- Perlecan forms complexes with Sonic Hedgehog that correlate with metastatic potential.
- Perlecan is highly expressed in androgen insensitive prostate cancer cell lines.
- Perlecan's effects on cell growth are independent of androgen signaling.
Takeaway
Perlecan helps prostate cancer cells grow by working with a signaling pathway called Sonic Hedgehog, even when there isn't much of a hormone called androgen around.
Methodology
Immunohistochemical analysis of prostate cancer tissue microarrays and cell line studies using siRNA.
Limitations
The study does not account for familial prostate cancer history in the analyzed samples.
Participant Demographics
Patients with prostate cancer, including those with aggressive tumors.
Statistical Information
P-Value
p<0.00005
Statistical Significance
p<0.00005
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website